Both of Us Are Wilson Disease Carriers — Can Our Baby Be Tested at Birth?

If you and your partner are both carriers of a Wilson disease mutation, each pregnancy carries a one-in-four chance of producing a child with WD. The answer to your question is yes — your baby can be tested at birth (or before birth), and if results suggest WD, treatment can begin well before symptoms emerge.

Understanding Your Situation First

When two carriers of an autosomal recessive condition have a child, the odds for each pregnancy are 25% / 50% / 25% — affected / carrier / unaffected. Each pregnancy is independent: the result of a previous pregnancy does not change the next pregnancy’s odds.¹

Wilson disease itself does not typically cause symptoms in infancy. Copper accumulates slowly in the liver, brain, and other organs over years. The age of presentation is broad: current AASLD 2022 guidance describes presentation as mainly, but not exclusively, between 3 and 55 years old, with confirmed cases as young as 3 and as old as the 70s–80s. Among children and adolescents, hepatic presentations dominate; in adults, neurological or psychiatric presentations are more common.²

Testing at Birth: What’s Available

Genetic testing at birth is a direct approach. If your specific family mutations have been identified, a DNA test on your baby can tell you whether the child has inherited both mutations, one, or neither.

However, a “two-mutation” genotype is not the whole diagnostic picture. Diagnosis of Wilson disease in a child uses the AASLD / Leipzig scoring system, which combines the genetic result with biochemical findings (ceruloplasmin, urinary copper, AST / ALT / ALP), liver biopsy where indicated, and ocular slit-lamp findings. Two pathogenic ATP7B variants on opposite chromosomes contribute 4 of the points needed for a “definite diagnosis”; a single variant adds only 1 point and does not rule out the disease without the rest of the work-up.³ In practice, a confirmed two-mutation genotype is highly diagnostic, but the full work-up should be performed at first presentation and at intervals afterward to track disease activity.²

A clinical-lab genotype result typically returns within 1–2 weeks (timing varies by laboratory and panel).

Testing Before Birth

If you want to know before the baby is born, two prenatal options exist, both established in obstetric practice:

• Chorionic villus sampling (CVS) at 10–13 weeks of pregnancy
• Amniocentesis at 15–20 weeks

Both procedures can obtain fetal cells for genetic testing when both parental mutations are known. Both carry a small procedural risk — discuss with your obstetrician and a maternal-fetal medicine specialist.⁴

If you are considering IVF, preimplantation genetic testing for monogenic conditions (PGT-M) allows screening of embryos before transfer. Access and cost vary significantly by country.

On Newborn Screening Specifically

As of 2026, no country offers a nationwide newborn screening program for Wilson disease. Washington State (USA) is the first jurisdiction to begin universal newborn screening for WD, as a state-level program.⁵ Routine markers used in newborn screening (ceruloplasmin, serum copper) are unreliable in newborns — ceruloplasmin is physiologically very low in all newborns up to about 6 months of age, regardless of WD status.²

Targeted genetic testing using your known family mutations could be a practical path, but the choice depends on your family-genetics specialist’s advice.

If the Baby Tests Positive

A positive genetic test alone does not predict severity or onset. Wilson disease has variable expressivity — some develop liver disease in childhood, others remain asymptomatic into adulthood.²³

For asymptomatic children under 3 years old, individualised care is essential. Zinc appears to be the preferred option for these very young asymptomatic children, but because treatment may have adverse effects on development, there is no consensus on whether to start treatment in the absence of organ-damage evidence. We recommend that you discuss this with your medical team.²

On Diet

For infants under 6 months, AASLD recommends breastmilk or standard formula rather than aggressive copper restriction, because young infants still need copper for postnatal development. However, no specific copper intake standard currently exists for infants who have WD but still require copper for postnatal development — parents should be aware of this.²

For unaffected infants born to mothers who have WD, the potential adverse effects of WD medication secreted into breastmilk must also be considered when choosing how to feed.²

For children 6 months and older, AASLD advises an age-appropriate variety of foods with emphasis on low- and moderate-copper choices while avoiding organ meats and shellfish; this is best designed with a registered dietitian familiar with WD.²

If the Baby Tests Negative

If the genotype test returns no mutations or one mutation, this could be reassuring — but should still be interpreted in the full clinical context with your specialist. A child with one ATP7B variant (a carrier) does not develop WD; the carrier status carries implications for their own future family planning, which can be discussed with a genetic counsellor in adolescence or early adulthood.

Practical Steps to Take Now

1. Confirm that both your specific ATP7B mutations are on record with a genetics laboratory.
2. Talk to your Wilson disease specialist during pregnancy about cord blood collection and the genotype panel that will be ordered.
3. Ask for a referral to a paediatric hepatologist with Wilson disease experience.
4. Connect with family screening resources.

This post is for educational purposes only. Your specific testing options, timing, and monitoring plan should be designed by your Wilson disease specialist and a clinical geneticist or genetic counsellor familiar with your family’s mutations.

References